Trial intelligence / Profile preview

Valacyclovir for HSV-2 Viral Shedding

NCT00306293Phase 4Completed

Sponsor
GSK
Start
Feb 2006
Primary completion
Nov 2006
Modality
Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of valaciclovir in genital herpes, sponsored by GSK. Started Feb 2006; status: completed.

02

Drugs

valaciclovir
03

Conditions

genital herpes

Beyond the preview

Go deeper on NCT00306293.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00306293.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call